"Expanding access to Lucira's first-of-its-kind test is critical in the face of the current surge of COVID-19 cases. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced that its Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test is now available in the Optum Store ( ). 11, 2022 (GLOBE NEWSWIRE) - Lucira Health, Inc. Lucira's test uniquely offers PCR accuracy and early detection without the 24 hour+ wait for resultsĮMERYVILLE, Calif., Jan. Lucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutesĪvailability in the Optum Store expands access to this unique testing option amidst a surge of US COVID-19 cases caused by the Omicron variant
0 Comments
Leave a Reply. |